Sasaki, K., Kantarjian, H., Short, N., Jain, N., Huang, X., Ravandi, F., Wierda, W., Borthakur, G., Issa, G., Valero, Y. A., Pemmaraju, N., Garcia-Manero, G., Garris, R., Jabbour, E. (2025). Blinatumomab and ponatinib vs. hyper-CVAD and ponatinib in patients with Philadelphia-chromosome positive acute lymphoblastic leukemia: A propensity score analysis. Blood. https://doi.org/10.1182/blood-2025-1578